Lung Cancer Clinical Trial

Empathic Communication Skills (ECS) Training

Summary

The purpose of this study is to find out if a new training program for cancer care providers called Empathic Communication Training (ECT) will be effective in helping care providers develop or increase the skills needed to provide care that limits lung cancer stigma.

View Full Description

Full Description

The aims of this study are:

to evaluate the effect of the ECS training on OCP primary outcomes (communication and empathic skill uptake) and secondary outcomes (ECS training appraisal - relevance, novelty, clarity; self-efficacy, empathy, compassion burn-out);

to evaluate the effect of the ECS training vs. WLC on patients' reported primary outcomes (lung cancer stigma), and secondary outcomes (perceived clinician empathy, satisfaction with communication, psychological distress, patients' experience of clinical encounter, and overall patient satisfaction).

Additionally, acceptance of referral to tobacco cessation (for those currently smoking) will be explored; and

to examine potential moderators of OCP (e.g., demographic characteristics, professional role characteristics) and patient outcomes (e.g., demographic characteristics, illness characteristics).

Our central hypothesis is that the ECS training will demonstrate significant short-term improvements in clinicians' uptake of empathic skills and self-efficacy and will be superior to WLC with regards to patient reported measures of stigma, clinician empathy, satisfaction, and overall experience.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Site Eligibility

Employs at least 15 FTE OCPs (i.e., oncologists, nurse practitioners and physician assistants) as per self report
Reports a clinic volume of at least 20 new lung cancer patients per month as per self report

OCP Participant Eligibility

OCPs who are thoracic oncology physicians (radiologists, medical oncologists, pulmonologists, and surgeons), NPs, or PAs and currently treating lung cancer patients, as per self-report;
OCP conducts consultations with lung cancer patients, as per self-report;
OCP sees at least 1 lung cancer patient per week, as per self-report;

Patient Eligibility

Patient under the care of a participating OCP as per self report;

English and/or Spanish speaking;

In general, which language do you prefer to receive your medical care, English/Spanish/both English and Spanish Equally?
If English, treat as fluent in English, no additional language questions
If Spanish, treat as fluent in Spanish, no additional language questions
If both English and Spanish equally, ask the follow-up questions and go with whichever language is endorsed as best. If endorsed equally, assign to category patient prefers
How well do you speak English? Not at all/ Not well/Well/Very well
How well do you speak Spanish? Not at all/Not well/Well/Very well
Is at least 18 years of age as per self report;
Has a history of suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note;
Is a former or current smoking as per self report;
Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report

Exclusion Criteria:

Patient Exclusion

Individuals of impaired decision-making capacity as per a clinician's judgment or as documented in the EMR.

Site and OCP Exclusion

None

Study is for people with:

Lung Cancer

Estimated Enrollment:

1232

Study ID:

NCT05456841

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Providence St. Joseph Health (Data Collection Only)
Irvine California, 92612, United States More Info
Areo Saffarzadeh, MD
Contact
949-364-6264
[email protected]
University of Kentucky (Data Collection Only)
Lexington Kentucky, 40536, United States More Info
Jessica Burris, PhD
Contact
859-257-9612
Munson Healthcare (Data Collection Only)
Traverse City Michigan, 49684, United States More Info
Kendra Worden, FNP
Contact
231-392-8400
Hackensack Meridian Health (Data collection only)
Hackensack New Jersey, 07601, United States More Info
David Greenberg, MD
Contact
551-996-8704
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York New York, 10065, United States More Info
Smita Banerjee, PhD
Contact
646-888-0011
Virtua Health (Data Collection Only)
Philadelphia Pennsylvania, 08060, United States More Info
Matthew Puc, MD
Contact
856-355-7176
Chesapeake Regional Healthcare (Data Collection Only)
Chesapeake Virginia, 23320, United States More Info
Stephen Noble, MD
Contact
757-842-4499

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

1232

Study ID:

NCT05456841

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.